4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Solvonis Therapeutics plc (SVNS) operates in the Biotechnology industry and is headquartered in London, United Kingdom with about 6 employees. Its market capitalization is roughly £10 million. In the fiscal year ended 2025-12-31, SVNS reported £0M in revenue and (£6M) in net income.
Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | £0M | £0M | £1M | £0M |
| Gross Profit | — | £0M | £0M | £0M |
| Operating Income (EBIT) | (£4M) | (£2M) | (£2M) | (£3M) |
| Net Income | (£6M) | (£2M) | (£3M) | (£3M) |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2024-12-31 |
|---|---|
| Total Revenue | £0M |
| Gross Profit | £0M |
| Operating Income (EBIT) | (£0M) |
| Net Income | (£0M) |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | £8M | £3M | £2M | £5M | — |
| Total Liabilities | £1M | £0M | £0M | £0M | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SVNS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms